+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cell Culture Market - Global Forecast 2026-2032- Product Image
Cell Culture Market - Global Forecast 2026-2032- Product Image
Sale

Cell Culture Market - Global Forecast 2026-2032

  • Report

  • 184 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4995205
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cell Culture Market is projected to reach USD 35.24 Billion in 2026. It is expected to continue growing at a CAGR of 14.66%, reaching USD 80.23 Billion by 2032.

Cell culture is a core enabling platform for biopharmaceutical manufacturing, vaccine production, regenerative medicine, toxicology testing, and advanced cell-based research. The market is anchored by validated demand for monoclonal antibodies, recombinant proteins, viral vectors, induced pluripotent stem cells, organoids, and cell therapies, all of which depend on reliable media, sera, supplements, bioreactors, cultureware, contamination control, and analytical workflows.

The strategic priority is clear: cell culture is no longer a laboratory support category but a high-value infrastructure layer for precision medicine and biologics manufacturing. Adoption is supported by continued regulatory approvals for biologics and cell therapies, wider use of single-use systems, and the global shift toward scalable, reproducible, animal-component-free, and chemically defined culture conditions.

Transformative Shifts in the Cell Culture Landscape

The cell culture landscape is being reshaped by the move from research-scale processes to industrialized, closed, and automated manufacturing ecosystems. Biopharma organizations are replacing open manual handling with single-use bioreactors, modular cleanrooms, automated cell processing, and real-time analytics to reduce contamination risk, improve batch consistency, and support faster technology transfer.

A second major shift is the transition from traditional serum-containing media toward serum-free, xeno-free, and chemically defined formulations. This shift is strongly aligned with regulatory expectations for traceability, reproducibility, and risk reduction, particularly in cell and gene therapy, vaccine production, and recombinant protein manufacturing. At the same time, organoid models, 3D culture, microphysiological systems, and high-content screening are expanding the role of cell culture in drug discovery and safety assessment.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a practical accelerator in cell culture by improving experimental design, media optimization, cell line development, image-based quality assessment, and predictive process control. AI-enabled analysis of microscopy, metabolite, transcriptomic, and bioreactor sensor data can identify early signals of cell stress, contamination risk, productivity loss, or differentiation drift before they compromise final output.

The cumulative impact is strongest when AI is connected to automation and digital manufacturing systems. In biologics and advanced therapy production, machine learning can support tighter control of pH, dissolved oxygen, feeding schedules, viable cell density, and critical quality attributes. The result is a more data-rich cell culture workflow that supports faster development cycles, stronger process understanding, improved deviation management, and stronger regulatory documentation.

Key Regional Insights: Asia-Pacific, North America, Europe & Emerging Regions

Asia-Pacific is gaining importance as China, India, Japan, South Korea, Singapore, and Australia expand biopharmaceutical manufacturing, vaccine capacity, and regenerative medicine research. Government-backed biotechnology programs, growing clinical trial activity, and investments in biologics infrastructure are strengthening regional demand for cell culture media, bioreactors, cell lines, 3D culture systems, and quality control technologies.

North America remains a leading center for cell culture innovation due to its concentration of biopharma developers, academic medical centers, contract development and manufacturing organizations, and regulatory experience through the U.S. FDA and Health Canada. Europe benefits from a mature pharmaceutical base, strong academic research, EMA-aligned regulatory systems, and demand for advanced therapy medicinal products, while Latin America is building capability through Brazil- and Mexico-led biologics, vaccine, and biosimilar initiatives. The Middle East is investing in life sciences diversification, particularly through Gulf health and industrial strategies, and Africa’s long-term opportunity is tied to vaccine localization, diagnostics, infectious disease research, and emerging biomanufacturing partnerships.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7 & NATO

ASEAN is becoming more relevant to cell culture through Singapore’s established biomedical manufacturing base and the broader region’s expanding clinical research, public health, and vaccine capabilities. The GCC is using national health and industrial diversification programs to build biotechnology capacity, with demand focused on diagnostics, cell therapy infrastructure, localized production, and partnerships with international manufacturers.

The European Union supports cell culture adoption through harmonized quality standards, strong research funding, and advanced therapy regulation, while BRICS countries represent substantial demand drivers through large patient populations, domestic biologics manufacturing, biosimilar development, and public health priorities. G7 economies continue to lead in biologics innovation, regulatory science, advanced automation, and high-end instrumentation, and NATO members benefit from biosecurity, pandemic preparedness, and resilient supply chain priorities that reinforce investment in cell culture-based vaccine, diagnostic, and therapeutic platforms.

Key Country Insights for Major Cell Culture Markets

The United States leads global cell culture demand through its biopharmaceutical pipeline, FDA-regulated biologics approvals, strong venture-backed biotechnology sector, and concentration of contract development and manufacturing organizations. Canada contributes through regenerative medicine clusters, academic hospitals, and public-private cell therapy initiatives, while Mexico is strengthening its role in nearshore manufacturing and clinical supply networks. Brazil remains Latin America’s most significant biologics and vaccine hub due to established public health manufacturing institutions, biosimilar activity, and a large domestic healthcare market.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine academic excellence, pharmaceutical manufacturing, clinical research networks, and advanced therapy research, while Russia maintains demand across vaccines, biologics, and domestic healthcare production. In Asia-Pacific, China is rapidly scaling biologics and cell therapy capabilities, India is expanding biosimilars and vaccine manufacturing, Japan has a well-defined regenerative medicine framework, South Korea is investing heavily in biologics manufacturing and outsourced development capacity, and Australia supports translational research and clinical development in cell and gene therapies.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize closed, scalable, and digitally monitored cell culture systems that support reproducibility from discovery through commercial manufacturing. Investment in serum-free and chemically defined media, single-use technologies, contamination control, validated raw material sourcing, and robust cell banking can reduce variability and improve regulatory readiness.

Organizations should also strengthen supply chain resilience by qualifying multiple suppliers for critical media components, plastics, analytical reagents, and process consumables. Strategic partnerships with contract manufacturers, academic centers, automation providers, and AI analytics specialists can accelerate process development while reducing capital intensity and time-to-clinic.

Research Methodology

This executive summary is developed using a structured secondary and primary research approach. The analysis considers publicly available regulatory documents, peer-reviewed scientific literature, clinical trial activity, government biotechnology programs, international quality standards, patent trends, manufacturing announcements, and validated industry observations across cell culture applications.

Research synthesis emphasizes triangulation across demand indicators, technology adoption, regulatory direction, regional manufacturing capacity, and end-user requirements. Insights are evaluated for relevance to media, reagents, sera alternatives, bioreactors, consumables, cell lines, 3D culture systems, automation, analytics, contamination control, and outsourced bioprocessing services.

Conclusion

The cell culture market is positioned for sustained strategic importance as biologics, vaccines, cell therapies, gene therapies, organoids, and precision medicine reshape healthcare and life sciences research. Demand is increasingly defined by quality, scalability, traceability, automation, and data integrity rather than by basic laboratory consumption alone.

Organizations that combine validated cell culture science with digital control, AI-assisted optimization, regulatory alignment, and resilient global supply chains will be best placed to capture long-term value. The next phase of competition will favor providers that help customers move faster from cell-based discovery to compliant, commercial-scale production.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Cell Culture Market, by Product Type
7.1. Introduction
7.2. Consumables
7.2.1. Media
7.2.1.1. Classical Media & Salts
7.2.1.2. Serum-Free Media
7.2.1.3. Specialty Media
7.2.2. Reagents
7.2.2.1. Attachment & Matrix Factors
7.2.2.2. Antibiotics/Antimycotics
7.2.3. Sera
7.2.3.1. Fetal Bovine Serum
7.2.3.2. Human Serum
7.2.4. Cell Culture Substrate
7.3. Instruments
7.3.1. Bioreactors
7.3.2. Centrifuges
7.3.3. Incubators
7.3.4. Culture Systems
7.3.5. Automated Cell Culture Equipment
7.4. Accessories & Supporting Materials
7.4.1. Culture Vessels & Plates
7.4.2. Tubing & Connectors
7.4.3. Filters
7.4.4. Cell Culture Bag Films
8. Cell Culture Market, by Technique
8.1. Introduction
8.2. 2D Culture
8.3. 3D Culture
8.4. Perfusion Culture
8.5. Suspension Culture
9. Cell Culture Market, by Cell Type
9.1. Introduction
9.2. Insect Cells
9.3. Mammalian Cells
9.4. Microbial Cells
9.5. Plant Cells
9.6. Stem Cells
10. Cell Culture Market, by Application
10.1. Introduction
10.2. Biopharmaceutical Manufacturing
10.2.1. Monoclonal Antibody Production
10.2.2. Vaccine Production
10.3. Cell Banking & Storage
10.3.1. Cryopreservation
10.3.2. Storage Services
10.4. Clinical Diagnostics
10.4.1. Immunodiagnostics
10.4.2. Molecular Diagnostics
10.5. Research & Development
10.5.1. Drug Discovery
10.5.2. Genetic Engineering
10.5.3. Toxicology
11. Cell Culture Market, by End User
11.1. Introduction
11.2. Academic & Research Institutes
11.3. Biotechnology Companies
11.4. Contract Research Organizations
11.5. Hospitals & Diagnostic Labs
11.6. Pharmaceutical Companies
12. Cell Culture Market, by Region
12.1. Asia-Pacific
12.2. Europe
12.3. North America
12.4. Latin America
12.5. Africa
12.6. Middle East
13. Cell Culture Market, by Group
13.1. NATO
13.2. G7
13.3. European Union
13.4. BRICS
13.5. ASEAN
13.6. GCC
14. Cell Culture Market, by Country
14.1. United States
14.2. China
14.3. Germany
14.4. Japan
14.5. India
14.6. United Kingdom
14.7. France
14.8. Canada
14.9. Brazil
14.10. Italy
14.11. Mexico
14.12. Australia
14.13. Russia
14.14. South Korea
14.15. Spain
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Adolf Kühner AG
16.2. Advancion Corporation
16.3. Agilent Technologies, Inc.
16.4. Becton, Dickinson and Company
16.5. Bio-Techne Corporation
16.6. BioSpherix Ltd.
16.7. Caisson Labs Inc.
16.8. CellGenix GmbH
16.9. Corning Incorporated
16.10. Danaher Corporation
16.11. Emulate, Inc.
16.12. Eppendorf AG
16.13. Fujifilm Holdings Corporation
16.14. Getinge AB
16.15. Hi-Media Laboratories
16.16. InSphero AG
16.17. Invivogen
16.18. Lonza Group
16.19. Merck & Co., Inc.
16.20. Miltenyi Biotec B.V. & Co. KG
16.21. PAN-Biotech GmbH
16.22. PromoCell GmbH
16.23. Sartorius AG
16.24. Solida Biotech GmBH
16.25. STEMCELL Technologies Canada Inc.
16.26. Synthecon, Incorporated
16.27. Thermo Fisher Scientific Inc.
16.28. VWR International, LLC by Avantor, Inc.
List of Figures
FIGURE 1. GLOBAL CELL CULTURE MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL CELL CULTURE MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL CELL CULTURE MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL CELL CULTURE MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL CELL CULTURE MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CELL CULTURE MARKET SIZE, BY CELL TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL CELL CULTURE MARKET SIZE, BY CELL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL CELL CULTURE MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL CELL CULTURE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL CELL CULTURE MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL CELL CULTURE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL CELL CULTURE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL CELL CULTURE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL CELL CULTURE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL CELL CULTURE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL CELL CULTURE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL CELL CULTURE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL CELL CULTURE MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL CELL CULTURE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL CONSUMABLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL CONSUMABLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL CONSUMABLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL MEDIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL MEDIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL MEDIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL CLASSICAL MEDIA & SALTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL CLASSICAL MEDIA & SALTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL CLASSICAL MEDIA & SALTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL SERUM-FREE MEDIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL SPECIALTY MEDIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL SPECIALTY MEDIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL SPECIALTY MEDIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL ATTACHMENT & MATRIX FACTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL ATTACHMENT & MATRIX FACTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL ATTACHMENT & MATRIX FACTORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL ANTIBIOTICS/ANTIMYCOTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL ANTIBIOTICS/ANTIMYCOTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL ANTIBIOTICS/ANTIMYCOTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL SERA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL SERA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL SERA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL FETAL BOVINE SERUM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL HUMAN SERUM MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL HUMAN SERUM MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL HUMAN SERUM MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL CELL CULTURE SUBSTRATE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL CELL CULTURE SUBSTRATE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL CELL CULTURE SUBSTRATE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL BIOREACTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL BIOREACTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL BIOREACTORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL CENTRIFUGES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL CENTRIFUGES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL CENTRIFUGES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL INCUBATORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL INCUBATORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL INCUBATORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL CULTURE SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL CULTURE SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL CULTURE SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL AUTOMATED CELL CULTURE EQUIPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL AUTOMATED CELL CULTURE EQUIPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL AUTOMATED CELL CULTURE EQUIPMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL ACCESSORIES & SUPPORTING MATERIALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL ACCESSORIES & SUPPORTING MATERIALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL ACCESSORIES & SUPPORTING MATERIALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL CULTURE VESSELS & PLATES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL CULTURE VESSELS & PLATES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL CULTURE VESSELS & PLATES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL TUBING & CONNECTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL TUBING & CONNECTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL TUBING & CONNECTORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL FILTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL FILTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL FILTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL CELL CULTURE BAG FILMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL CELL CULTURE BAG FILMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL CELL CULTURE BAG FILMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL 2D CULTURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL 2D CULTURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL 2D CULTURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL 3D CULTURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL 3D CULTURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL 3D CULTURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL PERFUSION CULTURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL PERFUSION CULTURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL PERFUSION CULTURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL SUSPENSION CULTURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL SUSPENSION CULTURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL SUSPENSION CULTURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL CELL CULTURE MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL INSECT CELLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL INSECT CELLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL INSECT CELLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL MAMMALIAN CELLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL MAMMALIAN CELLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL MAMMALIAN CELLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL MICROBIAL CELLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL MICROBIAL CELLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL MICROBIAL CELLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL PLANT CELLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL PLANT CELLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL PLANT CELLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL STEM CELLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL STEM CELLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL STEM CELLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL CELL CULTURE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL BIOPHARMACEUTICAL MANUFACTURING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL BIOPHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL BIOPHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL MONOCLONAL ANTIBODY PRODUCTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL MONOCLONAL ANTIBODY PRODUCTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL MONOCLONAL ANTIBODY PRODUCTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL VACCINE PRODUCTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL VACCINE PRODUCTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL VACCINE PRODUCTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL CELL BANKING & STORAGE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL CELL BANKING & STORAGE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL CELL BANKING & STORAGE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL CRYOPRESERVATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL CRYOPRESERVATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL CRYOPRESERVATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL STORAGE SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL STORAGE SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL STORAGE SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL IMMUNODIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL IMMUNODIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL IMMUNODIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL RESEARCH & DEVELOPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL RESEARCH & DEVELOPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL RESEARCH & DEVELOPMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL DRUG DISCOVERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL DRUG DISCOVERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL GENETIC ENGINEERING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL GENETIC ENGINEERING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL GENETIC ENGINEERING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL TOXICOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL TOXICOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL TOXICOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL CELL CULTURE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 143. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 144. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 145. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 146. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 147. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 148. GLOBAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 149. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 150. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 151. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 152. GLOBAL HOSPITALS & DIAGNOSTIC LABS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 153. GLOBAL HOSPITALS & DIAGNOSTIC LABS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 154. GLOBAL HOSPITALS & DIAGNOSTIC LABS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 155. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 156. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 157. GLOBAL PHARMACEUTICAL COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 158. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY MEDIA, 2017-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY SERA, 2017-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY ACCESSORIES & SUPPORTING MATERIALS, 2017-2032 (USD MILLION)
TABLE 167. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 168. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 169. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 170. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2017-2032 (USD MILLION)
TABLE 171. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY CELL BANKING & STORAGE, 2017-2032 (USD MILLION)
TABLE 172. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 173. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2017-2032 (USD MILLION)
TABLE 174. ASIA-PACIFIC CELL CULTURE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 175. EUROPE CELL CULTURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 176. EUROPE CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 177. EUROPE CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 178. EUROPE CELL CULTURE MARKET SIZE, BY MEDIA, 2017-2032 (USD MILLION)
TABLE 179. EUROPE CELL CULTURE MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 180. EUROPE CELL CULTURE MARKET SIZE, BY SERA, 2017-2032 (USD MILLION)
TABLE 181. EUROPE CELL CULTURE MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 182. EUROPE CELL CULTURE MARKET SIZE, BY ACCESSORIES & SUPPORTING MATERIALS, 2017-2032 (USD MILLION)
TABLE 183. EUROPE CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 184. EUROPE CELL CULTURE MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 185. EUROPE CELL CULTURE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 186. EUROPE CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2017-2032 (USD MILLION)
TABLE 187. EUROPE CELL CULTURE MARKET SIZE, BY CELL BANKING & STORAGE, 2017-2032 (USD MILLION)
TABLE 188. EUROPE CELL CULTURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 189. EUROPE CELL CULTURE MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2017-2032 (USD MILLION)
TABLE 190. EUROPE CELL CULTURE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 191. NORTH AMERICA CELL CULTURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 192. NORTH AMERICA CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 193. NORTH AMERICA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 194. NORTH AMERICA CELL CULTURE MARKET SIZE, BY MEDIA, 2017-2032 (USD MILLION)
TABLE 195. NORTH AMERICA CELL CULTURE MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 196. NORTH AMERICA CELL CULTURE MARKET SIZE, BY SERA, 2017-2032 (USD MILLION)
TABLE 197. NORTH AMERICA CELL CULTURE MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 198. NORTH AMERICA CELL CULTURE MARKET SIZE, BY ACCESSORIES & SUPPORTING MATERIALS, 2017-2032 (USD MILLION)
TABLE 199. NORTH AMERICA CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 200. NORTH AMERICA CELL CULTURE MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 201. NORTH AMERICA CELL CULTURE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 202. NORTH AMERICA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2017-2032 (USD MILLION)
TABLE 203. NORTH AMERICA CELL CULTURE MARKET SIZE, BY CELL BANKING & STORAGE, 2017-2032 (USD MILLION)
TABLE 204. NORTH AMERICA CELL CULTURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 205. NORTH AMERICA CELL CULTURE MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2017-2032 (USD MILLION)
TABLE 206. NORTH AMERICA CELL CULTURE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 207. LATIN AMERICA CELL CULTURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 208. LATIN AMERICA CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 209. LATIN AMERICA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 210. LATIN AMERICA CELL CULTURE MARKET SIZE, BY MEDIA, 2017-2032 (USD MILLION)
TABLE 211. LATIN AMERICA CELL CULTURE MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 212. LATIN AMERICA CELL CULTURE MARKET SIZE, BY SERA, 2017-2032 (USD MILLION)
TABLE 213. LATIN AMERICA CELL CULTURE MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 214. LATIN AMERICA CELL CULTURE MARKET SIZE, BY ACCESSORIES & SUPPORTING MATERIALS, 2017-2032 (USD MILLION)
TABLE 215. LATIN AMERICA CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 216. LATIN AMERICA CELL CULTURE MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 217. LATIN AMERICA CELL CULTURE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 218. LATIN AMERICA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2017-2032 (USD MILLION)
TABLE 219. LATIN AMERICA CELL CULTURE MARKET SIZE, BY CELL BANKING & STORAGE, 2017-2032 (USD MILLION)
TABLE 220. LATIN AMERICA CELL CULTURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 221. LATIN AMERICA CELL CULTURE MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2017-2032 (USD MILLION)
TABLE 222. LATIN AMERICA CELL CULTURE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 223. AFRICA CELL CULTURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 224. AFRICA CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 225. AFRICA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 226. AFRICA CELL CULTURE MARKET SIZE, BY MEDIA, 2017-2032 (USD MILLION)
TABLE 227. AFRICA CELL CULTURE MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 228. AFRICA CELL CULTURE MARKET SIZE, BY SERA, 2017-2032 (USD MILLION)
TABLE 229. AFRICA CELL CULTURE MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 230. AFRICA CELL CULTURE MARKET SIZE, BY ACCESSORIES & SUPPORTING MATERIALS, 2017-2032 (USD MILLION)
TABLE 231. AFRICA CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 232. AFRICA CELL CULTURE MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 233. AFRICA CELL CULTURE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 234. AFRICA CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2017-2032 (USD MILLION)
TABLE 235. AFRICA CELL CULTURE MARKET SIZE, BY CELL BANKING & STORAGE, 2017-2032 (USD MILLION)
TABLE 236. AFRICA CELL CULTURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 237. AFRICA CELL CULTURE MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2017-2032 (USD MILLION)
TABLE 238. AFRICA CELL CULTURE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 239. MIDDLE EAST CELL CULTURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 240. MIDDLE EAST CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 241. MIDDLE EAST CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 242. MIDDLE EAST CELL CULTURE MARKET SIZE, BY MEDIA, 2017-2032 (USD MILLION)
TABLE 243. MIDDLE EAST CELL CULTURE MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 244. MIDDLE EAST CELL CULTURE MARKET SIZE, BY SERA, 2017-2032 (USD MILLION)
TABLE 245. MIDDLE EAST CELL CULTURE MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 246. MIDDLE EAST CELL CULTURE MARKET SIZE, BY ACCESSORIES & SUPPORTING MATERIALS, 2017-2032 (USD MILLION)
TABLE 247. MIDDLE EAST CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 248. MIDDLE EAST CELL CULTURE MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 249. MIDDLE EAST CELL CULTURE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 250. MIDDLE EAST CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2017-2032 (USD MILLION)
TABLE 251. MIDDLE EAST CELL CULTURE MARKET SIZE, BY CELL BANKING & STORAGE, 2017-2032 (USD MILLION)
TABLE 252. MIDDLE EAST CELL CULTURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 253. MIDDLE EAST CELL CULTURE MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2017-2032 (USD MILLION)
TABLE 254. MIDDLE EAST CELL CULTURE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 255. GLOBAL CELL CULTURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 256. NATO CELL CULTURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 257. NATO CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 258. NATO CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 259. NATO CELL CULTURE MARKET SIZE, BY MEDIA, 2017-2032 (USD MILLION)
TABLE 260. NATO CELL CULTURE MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 261. NATO CELL CULTURE MARKET SIZE, BY SERA, 2017-2032 (USD MILLION)
TABLE 262. NATO CELL CULTURE MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 263. NATO CELL CULTURE MARKET SIZE, BY ACCESSORIES & SUPPORTING MATERIALS, 2017-2032 (USD MILLION)
TABLE 264. NATO CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 265. NATO CELL CULTURE MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 266. NATO CELL CULTURE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 267. NATO CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2017-2032 (USD MILLION)
TABLE 268. NATO CELL CULTURE MARKET SIZE, BY CELL BANKING & STORAGE, 2017-2032 (USD MILLION)
TABLE 269. NATO CELL CULTURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 270. NATO CELL CULTURE MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2017-2032 (USD MILLION)
TABLE 271. NATO CELL CULTURE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 272. G7 CELL CULTURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 273. G7 CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 274. G7 CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 275. G7 CELL CULTURE MARKET SIZE, BY MEDIA, 2017-2032 (USD MILLION)
TABLE 276. G7 CELL CULTURE MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 277. G7 CELL CULTURE MARKET SIZE, BY SERA, 2017-2032 (USD MILLION)
TABLE 278. G7 CELL CULTURE MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 279. G7 CELL CULTURE MARKET SIZE, BY ACCESSORIES & SUPPORTING MATERIALS, 2017-2032 (USD MILLION)
TABLE 280. G7 CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 281. G7 CELL CULTURE MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 282. G7 CELL CULTURE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 283. G7 CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2017-2032 (USD MILLION)
TABLE 284. G7 CELL CULTURE MARKET SIZE, BY CELL BANKING & STORAGE, 2017-2032 (USD MILLION)
TABLE 285. G7 CELL CULTURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 286. G7 CELL CULTURE MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2017-2032 (USD MILLION)
TABLE 287. G7 CELL CULTURE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 288. EUROPEAN UNION CELL CULTURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 289. EUROPEAN UNION CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 290. EUROPEAN UNION CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 291. EUROPEAN UNION CELL CULTURE MARKET SIZE, BY MEDIA, 2017-2032 (USD MILLION)
TABLE 292. EUROPEAN UNION CELL CULTURE MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 293. EUROPEAN UNION CELL CULTURE MARKET SIZE, BY SERA, 2017-2032 (USD MILLION)
TABLE 294. EUROPEAN UNION CELL CULTURE MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 295. EUROPEAN UNION CELL CULTURE MARKET SIZE, BY ACCESSORIES & SUPPORTING MATERIALS, 2017-2032 (USD MILLION)
TABLE 296. EUROPEAN UNION CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 297. EUROPEAN UNION CELL CULTURE MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 298. EUROPEAN UNION CELL CULTURE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 299. EUROPEAN UNION CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2017-2032 (USD MILLION)
TABLE 300. EUROPEAN UNION CELL CULTURE MARKET SIZE, BY CELL BANKING & STORAGE, 2017-2032 (USD MILLION)
TABLE 301. EUROPEAN UNION CELL CULTURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 302. EUROPEAN UNION CELL CULTURE MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2017-2032 (USD MILLION)
TABLE 303. EUROPEAN UNION CELL CULTURE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 304. BRICS CELL CULTURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 305. BRICS CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 306. BRICS CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 307. BRICS CELL CULTURE MARKET SIZE, BY MEDIA, 2017-2032 (USD MILLION)
TABLE 308. BRICS CELL CULTURE MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 309. BRICS CELL CULTURE MARKET SIZE, BY SERA, 2017-2032 (USD MILLION)
TABLE 310. BRICS CELL CULTURE MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 311. BRICS CELL CULTURE MARKET SIZE, BY ACCESSORIES & SUPPORTING MATERIALS, 2017-2032 (USD MILLION)
TABLE 312. BRICS CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 313. BRICS CELL CULTURE MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 314. BRICS CELL CULTURE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 315. BRICS CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2017-2032 (USD MILLION)
TABLE 316. BRICS CELL CULTURE MARKET SIZE, BY CELL BANKING & STORAGE, 2017-2032 (USD MILLION)
TABLE 317. BRICS CELL CULTURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 318. BRICS CELL CULTURE MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2017-2032 (USD MILLION)
TABLE 319. BRICS CELL CULTURE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 320. ASEAN CELL CULTURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 321. ASEAN CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 322. ASEAN CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 323. ASEAN CELL CULTURE MARKET SIZE, BY MEDIA, 2017-2032 (USD MILLION)
TABLE 324. ASEAN CELL CULTURE MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 325. ASEAN CELL CULTURE MARKET SIZE, BY SERA, 2017-2032 (USD MILLION)
TABLE 326. ASEAN CELL CULTURE MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 327. ASEAN CELL CULTURE MARKET SIZE, BY ACCESSORIES & SUPPORTING MATERIALS, 2017-2032 (USD MILLION)
TABLE 328. ASEAN CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 329. ASEAN CELL CULTURE MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 330. ASEAN CELL CULTURE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 331. ASEAN CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2017-2032 (USD MILLION)
TABLE 332. ASEAN CELL CULTURE MARKET SIZE, BY CELL BANKING & STORAGE, 2017-2032 (USD MILLION)
TABLE 333. ASEAN CELL CULTURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 334. ASEAN CELL CULTURE MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2017-2032 (USD MILLION)
TABLE 335. ASEAN CELL CULTURE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 336. GCC CELL CULTURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 337. GCC CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 338. GCC CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 339. GCC CELL CULTURE MARKET SIZE, BY MEDIA, 2017-2032 (USD MILLION)
TABLE 340. GCC CELL CULTURE MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 341. GCC CELL CULTURE MARKET SIZE, BY SERA, 2017-2032 (USD MILLION)
TABLE 342. GCC CELL CULTURE MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 343. GCC CELL CULTURE MARKET SIZE, BY ACCESSORIES & SUPPORTING MATERIALS, 2017-2032 (USD MILLION)
TABLE 344. GCC CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 345. GCC CELL CULTURE MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 346. GCC CELL CULTURE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 347. GCC CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2017-2032 (USD MILLION)
TABLE 348. GCC CELL CULTURE MARKET SIZE, BY CELL BANKING & STORAGE, 2017-2032 (USD MILLION)
TABLE 349. GCC CELL CULTURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 350. GCC CELL CULTURE MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2017-2032 (USD MILLION)
TABLE 351. GCC CELL CULTURE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 352. GLOBAL CELL CULTURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 353. UNITED STATES CELL CULTURE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 354. UNITED STATES CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 355. UNITED STATES CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 356. UNITED STATES CELL CULTURE MARKET SIZE, BY MEDIA, 2017-2032 (USD MILLION)
TABLE 357. UNITED STATES CELL CULTURE MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 358. UNITED STATES CELL CULTURE MARKET SIZE, BY SERA, 2017-2032 (USD MILLION)
TABLE 359. UNITED STATES CELL CULTURE MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 360. UNITED STATES CELL CULTURE MARKET SIZE, BY ACCESSORIES & SUPPORTING MATERIALS, 2017-2032 (USD MILLION)
TABLE 361. UNITED STATES CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 362. UNITED STATES CELL CULTURE MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 363. UNITED STATES CELL CULTURE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 364. UNITED STATES CELL CULTURE MARKET SIZE, BY BIOPHARMACEUTICAL MANUFACTURING, 2017-2032 (USD MILLION)
TABLE 365. UNITED STATES CELL CULTURE MARKET SIZE, BY CELL BANKING & STORAGE, 2017-2032 (USD MILLION)
TABLE 366. UNITED STATES CELL CULTURE MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 367. UNITED STATES CELL CULTURE MARKET SIZE, BY RESEARCH & DEVELOPMENT, 2017-2032 (USD MILLION)
TABLE 368. UNITED STATES CELL CULTURE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 369. CHINA CELL CULTURE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 370. CHINA CELL CULTURE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 371. CHINA CELL CULTURE MARKET SIZE, BY CONSUMABLES, 2017-2032 (USD MILLION)
TABLE 372. CHINA CELL CULTURE MARKET SIZE, BY MEDIA, 2017-2032 (USD MILLION)
TABLE 373. CHINA CELL CULTURE MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 374. CHINA CELL CULTURE MARKET SIZE, BY SERA, 2017-2032 (USD MILLION)
TABLE 375. CHINA CELL CULTURE MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 376. CHINA CELL CULTURE MARKET SIZE, BY ACCESSORIES & SUPPORTING MATERIALS, 2017-2032 (USD MILLION)
TABLE 377. CHINA CELL CULTURE MARKET SIZE, BY TECHNIQUE, 2017-2032 (USD MILLION)
TABLE 378. CHINA CELL CULTURE MARKET SIZE, BY CELL TYPE, 2017-2032 (USD MILLION)
TABLE 379. CHINA CELL CULTU

Companies Mentioned

  • Adolf Kühner AG
  • Advancion Corporation
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Techne Corporation
  • BioSpherix Ltd.
  • Caisson Labs Inc.
  • CellGenix GmbH
  • Corning Incorporated
  • Danaher Corporation
  • Emulate, Inc.
  • Eppendorf AG
  • Fujifilm Holdings Corporation
  • Getinge AB
  • Hi-Media Laboratories
  • InSphero AG
  • Invivogen
  • Lonza Group
  • Merck & Co., Inc.
  • Miltenyi Biotec B.V. & Co. KG
  • PAN-Biotech GmbH
  • PromoCell GmbH
  • Sartorius AG
  • Solida Biotech GmBH
  • STEMCELL Technologies Canada Inc.
  • Synthecon, Incorporated
  • Thermo Fisher Scientific Inc.
  • VWR International, LLC by Avantor, Inc.

Table Information

Report AttributeDetails
No. of Pages184
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 35.24 Billion
Forecasted Market Value ( USD ) by 2032 $ 80.23 Billion
Compound Annual Growth Rate14.6%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Cell Culture Reagents Market - Global Forecast 2026-2032 - Product Image

Cell Culture Reagents Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Cell Culture Media Market - Global Forecast 2026-2032 - Product Image

Cell Culture Media Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Cell Culture Market by Consumables, Vessels, Equipment, Application, Competition - Global Forecast to 2031 - Product Image

Cell Culture Market by Consumables, Vessels, Equipment, Application, Competition - Global Forecast to 2031

  • Report
  • 765 Pages
  • Global
From
Cell Culture Vessels - Global Strategic Business Report - Product Image

Cell Culture Vessels - Global Strategic Business Report

  • Report
  • 387 Pages
  • Global
From
3D Cell Culture - Global Strategic Business Report - Product Image

3D Cell Culture - Global Strategic Business Report

  • Report
  • 150 Pages
  • Global
From

About the Market

Cell culture is a process used in biotechnology to grow cells in a controlled environment. It is used to study the behavior of cells, to produce proteins and other biological molecules, and to create vaccines and other drugs. Cell culture is also used to create cell lines, which are used in research and drug development. Cell culture is a key component of biotechnology, as it allows scientists to study the behavior of cells in a controlled environment. It is used to study the effects of drugs, to produce proteins and other biological molecules, and to create vaccines and other drugs. Cell culture is also used to create cell lines, which are used in research and drug development. Cell culture is a rapidly growing market, with many companies offering products and services related to cell culture. Companies such as Thermo Fisher Scientific, Merck KGaA, Corning, and Lonza Group provide products such as cell culture media, reagents, and equipment. Other companies such as Bio-Rad Laboratories, PromoCell, and Cell Applications offer services such as cell line development, cell banking, and cell line authentication. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.